Granite Bio
About Granite Bio
Granite Bio is focused on developing immunology assets, pioneering a new approach to tackling inflammation, autoimmunity, and fibrosis by addressing fundamental disease drivers at their source. The company is developing first-in-class therapeutic antibodies aimed at depleting pathogenic cells.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series B | Apr 24, 2025 | $70.0M | Versant Ventures |
Founders
No founder information available.
Investors
Versant Ventures
Venture Capital
Recent Mentions
Versant Ventures newest Swiss startup, Granite Bio, launches with a $70M series B, bringing total raised for two #immunology assets to $100M. https://t.co/wJ9kunwHdP #biopharma #inflammation #ulcerativecolitis #financing
Versant Ventures newest Swiss startup, Granite Bio, launches with a $70M series B, bringing total raised for two #immunology assets to $100M. https://t.co/wJ9kunwHdP #biopharma #inflammation #ulcerativecolitis #financing
Similar Startups
LTZ Therapeutics
83% matchLTZ Therapeutics is an immunotherapy-focused global biotech startup dedicated to developing myeloid ...
Glacier Tech Inc.
82% matchGlacier Tech Inc. is a pioneering recycling robotics firm that focuses on automating the recycling p...
HexaHealth
80% matchHexaHealth is a healthcare startup focused on providing innovative solutions to improve patient care...
InfraMarket
80% matchB2B construction materials platform